Use of serotonergic drugs to treat virus-induced thrombocytopenia
The present invention relates to the use of serotonergic compounds for the treatment of virus-induced thrombocytopenia. More particularly, the invention relates to methods of treating thrombocytopenia by blocking serotonin activity. For example, inhibitors of receptor 5HT2A and/or receptor 5HT1A and...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
30.08.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!